Press Releases

The companies agree to a worldwide Human Platelet Lysate (HPL) Patent License and Assignment Agreement regarding Human Platelet Lysate (HPL) cell culture supplements, including redirection of HPL customers from Macopharma to PL BioScience. PL BioScience GmbH, a German life science company specializing in the production and

READ MORE

“Cell cultivation: Anticoagulant-free Human Platelet Lysate” About LABO Journal LABO, a German journal for laboratory technology, introduced our new product ELAREM™ Perform-FD PLUS in the article: “Cell cultivation: Anticoagulant-free Human Platelet Lysate”. The LABO journal is specialized in scientific news, inventions and updates concerning the daily lab

READ MORE

New press release on our Human Platelet Lysate. Read the article (in German) online via: https://www.labo.de/zell-und-mikrobiologie/tierfreies-naehrmedium.htm The LABO journal is specialized in scientific news, inventions and updates concerning the daily lab routine. So, it addresses analytics and diagnostics, new lab techniques, chemistry, food, environmental influences as well as

READ MORE

The TechVision Fonds brings in new capital in PL BioScience We are proud to announce that with the support of SilverSky LifeSciences we successfully managed to convince the TechVision Fonds to invest in our start-up business. The TechVision Fonds, managed by the S-UBG group, supports innovative start-up

READ MORE

Cell Culture innovation without the need of animal serum Our innovative cell culture media pave the way to a new standard of cell cultivation, without the need of animal serum. Human Platelet Lysate is highly efficient It is highly efficient, resource-preserving and replaces procedures associated with animal suffering:

READ MORE
Any questions?
close slider

Any questions?

Please contact us:

support@pl-bioscience.com

+49 (0) 241 95719-100